Birdwatch Note
2024-05-04 13:40:30 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
実は、イベルメクチンだけではがんは治りません。 研究者は「特定の時間に特定の用量を投与した場合にのみ効果がある」と主張しており、現在も研究が続けられています。 しかしながら、がんを患う人間に対して成功した結果をもたらした臨床試験の報告はまだありません。 https://factcheck.afp.com/doc.afp.com.33E87YP https://apnews.com/article/fact-check-ivermectin-nih-cancer-cure-629592291079 アメリカのFDAは、「自己判断で服用して入院した患者がいる」としたうえで「大量に摂取しても大丈夫と聞いたかもしれないが、間違いで非常に危険だ。吐き気や下痢、けいれんなど深刻な被害を引き起こす可能性があるだけでなく、死に至ることもある」と注意を呼びかけています。 https://www3.nhk.or.jp/news/html/20210823/k10013218191000.html
Written by 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1786745282950300039
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1786752766645502362
- noteId - 1786752766645502362
- participantId -
- noteAuthorParticipantId - 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2 Participant Details
- createdAtMillis - 1714830030486
- tweetId - 1786745282950300039
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 実は、イベルメクチンだけではがんは治りません。 研究者は「特定の時間に特定の用量を投与した場合にのみ効果がある」と主張しており、現在も研究が続けられています。 しかしながら、がんを患う人間に対して成功した結果をもたらした臨床試験の報告はまだありません。 https://factcheck.afp.com/doc.afp.com.33E87YP https://apnews.com/article/fact-check-ivermectin-nih-cancer-cure-629592291079 アメリカのFDAは、「自己判断で服用して入院した患者がいる」としたうえで「大量に摂取しても大丈夫と聞いたかもしれないが、間違いで非常に危険だ。吐き気や下痢、けいれんなど深刻な被害を引き起こす可能性があるだけでなく、死に至ることもある」と注意を呼びかけています。 https://www3.nhk.or.jp/news/html/20210823/k10013218191000.html
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-05-04 13:40:30 UTC (1714830030486) |
2024-05-05 03:07:17 UTC (1714878437561) |
CURRENTLY_RATED_HELPFUL | 2024-05-05 13:07:44 UTC (1714914464458) |
CURRENTLY_RATED_HELPFUL | 2024-05-05 03:07:17 UTC (1714878437561) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-05-05 04:06:27 -0500 | Rating Details | |
2024-05-05 01:03:01 -0500 | Rating Details | |
2024-05-04 22:33:04 -0500 | Rating Details | |
2024-05-04 22:25:06 -0500 | Rating Details | |
2024-05-04 18:41:15 -0500 | Rating Details | |
2024-05-04 17:53:33 -0500 | Rating Details | |
2024-05-04 17:29:07 -0500 | Rating Details | |
2024-05-04 16:14:02 -0500 | Rating Details | |
2024-05-04 15:27:16 -0500 | Rating Details | |
2024-05-04 15:11:53 -0500 | Rating Details | |
2024-05-04 14:35:33 -0500 | Rating Details | |
2024-05-04 14:06:03 -0500 | Rating Details | |
2024-05-04 14:04:55 -0500 | Rating Details | |
2024-05-04 13:20:19 -0500 | Rating Details | |
2024-05-04 12:58:44 -0500 | Rating Details | |
2024-05-04 11:49:39 -0500 | Rating Details | |
2024-05-04 11:00:10 -0500 | Rating Details | |
2024-05-04 10:40:30 -0500 | Rating Details | |
2024-05-04 09:58:04 -0500 | Rating Details | |
2024-05-04 09:55:36 -0500 | Rating Details | |
2024-05-04 09:51:02 -0500 | Rating Details | |
2024-05-04 09:43:50 -0500 | Rating Details | |
2024-05-04 09:43:18 -0500 | Rating Details | |
2024-05-04 09:42:22 -0500 | Rating Details | |
2024-05-04 09:38:11 -0500 | Rating Details | |
2024-05-04 09:24:05 -0500 | Rating Details | |
2024-05-04 09:21:47 -0500 | Rating Details | |
2024-05-04 09:05:01 -0500 | Rating Details | |
2024-05-04 08:58:49 -0500 | Rating Details | |
2024-05-04 08:53:10 -0500 | Rating Details | |
2024-05-04 08:51:22 -0500 | Rating Details | |
2024-05-05 05:34:12 -0500 | Rating Details | |
2024-05-05 02:05:16 -0500 | Rating Details | |
2024-05-05 00:56:31 -0500 | Rating Details | |
2024-05-05 00:26:20 -0500 | Rating Details | |
2024-05-05 00:03:44 -0500 | Rating Details | |
2024-05-04 22:20:33 -0500 | Rating Details | |
2024-05-04 18:41:35 -0500 | Rating Details | |
2024-05-04 18:02:45 -0500 | Rating Details | |
2024-05-04 17:22:52 -0500 | Rating Details | |
2024-05-04 15:20:32 -0500 | Rating Details | |
2024-05-04 14:23:07 -0500 | Rating Details | |
2024-05-04 13:51:44 -0500 | Rating Details | |
2024-05-04 12:59:44 -0500 | Rating Details | |
2024-05-04 10:54:24 -0500 | Rating Details | |
2024-05-04 10:33:04 -0500 | Rating Details | |
2024-05-04 10:23:44 -0500 | Rating Details | |
2024-05-04 10:09:12 -0500 | Rating Details | |
2024-05-04 09:49:37 -0500 | Rating Details | |
2024-05-04 09:36:07 -0500 | Rating Details | |
2024-05-04 09:35:30 -0500 | Rating Details | |
2024-05-04 09:20:52 -0500 | Rating Details | |
2024-05-04 09:18:21 -0500 | Rating Details | |
2024-05-04 08:55:16 -0500 | Rating Details | |
2024-05-04 08:49:02 -0500 | Rating Details | |
2024-05-05 22:42:28 -0500 | Rating Details | |
2024-05-05 08:13:26 -0500 | Rating Details | |
2024-05-08 05:27:31 -0500 | Rating Details | |
2024-05-07 10:12:13 -0500 | Rating Details | |
2024-05-06 22:04:20 -0500 | Rating Details | |
2024-05-05 03:00:03 -0500 | Rating Details | |
2024-05-04 18:58:47 -0500 | Rating Details | |
2024-05-04 17:19:18 -0500 | Rating Details | |
2024-05-04 17:12:51 -0500 | Rating Details | |
2024-05-04 16:40:35 -0500 | Rating Details | |
2024-05-04 15:22:53 -0500 | Rating Details | |
2024-05-04 14:30:29 -0500 | Rating Details | |
2024-05-04 14:26:54 -0500 | Rating Details | |
2024-05-04 13:31:10 -0500 | Rating Details | |
2024-05-04 11:00:57 -0500 | Rating Details | |
2024-05-04 10:25:52 -0500 | Rating Details | |
2024-05-04 10:23:17 -0500 | Rating Details | |
2024-05-04 10:17:31 -0500 | Rating Details | |
2024-05-04 10:14:53 -0500 | Rating Details | |
2024-05-04 10:03:47 -0500 | Rating Details | |
2024-05-04 10:00:59 -0500 | Rating Details | |
2024-05-04 09:57:37 -0500 | Rating Details | |
2024-05-04 09:32:49 -0500 | Rating Details | |
2024-05-04 09:30:48 -0500 | Rating Details | |
2024-05-04 09:27:30 -0500 | Rating Details | |
2024-05-04 09:08:03 -0500 | Rating Details | |
2024-05-04 09:03:39 -0500 | Rating Details | |
2024-05-04 08:51:07 -0500 | Rating Details | |
2024-05-04 08:50:11 -0500 | Rating Details | |
2024-05-11 13:06:35 -0500 | Rating Details | |
2024-05-06 08:47:30 -0500 | Rating Details | |
2024-05-06 02:31:47 -0500 | Rating Details | |
2024-05-05 03:34:49 -0500 | Rating Details | |
2024-05-05 03:05:54 -0500 | Rating Details | |
2024-05-05 02:38:50 -0500 | Rating Details | |
2024-05-04 22:30:39 -0500 | Rating Details | |
2024-05-04 20:26:21 -0500 | Rating Details | |
2024-05-04 18:50:56 -0500 | Rating Details | |
2024-05-04 16:12:17 -0500 | Rating Details | |
2024-05-04 12:42:31 -0500 | Rating Details | |
2024-05-04 11:20:19 -0500 | Rating Details | |
2024-05-04 10:42:22 -0500 | Rating Details | |
2024-05-04 10:32:23 -0500 | Rating Details | |
2024-05-04 10:31:27 -0500 | Rating Details | |
2024-05-04 10:20:07 -0500 | Rating Details | |
2024-05-04 10:16:11 -0500 | Rating Details | |
2024-05-04 09:27:51 -0500 | Rating Details | |
2024-05-04 09:23:43 -0500 | Rating Details | |
2024-05-04 09:22:37 -0500 | Rating Details | |
2024-05-04 08:43:59 -0500 | Rating Details | |
2024-05-04 22:30:35 -0500 | Rating Details | |
2024-05-04 17:18:24 -0500 | Rating Details | |
2024-05-04 10:19:15 -0500 | Rating Details | |
2024-05-04 09:48:42 -0500 | Rating Details | |
2024-05-07 10:21:42 -0500 | Rating Details | |
2024-05-05 07:30:28 -0500 | Rating Details | |
2024-05-05 06:44:15 -0500 | Rating Details | |
2024-05-05 00:39:44 -0500 | Rating Details | |
2024-05-04 09:31:53 -0500 | Rating Details | |
2024-05-04 09:15:32 -0500 | Rating Details | |
2024-05-07 10:18:19 -0500 | Rating Details |